1 – Scheme overview

This external quality assessment allows you to check the accuracy of the results rendered by your point of care testing according to the standard NF EN ISO 22870 and ISO 15189. As the samples are ready for use, they can be analyzed directly by healthcare staff as a real patient sample.

3 possible cumulative options (each option is sold separately):

• Biochemistry / Hematology option (BDB).
• INR option (BDH).
• D-Dimer option (BDDI).

For the 3 options, one registration allows acces to 6 entries of results per analyte.

Program limited to France excluding Corsica.

2 – Assessment frequency

Biochemistry / Hematology (BDB) option:

• Number of investigations per year: 4
• Number of control samples per investigation: 1
• Number of samples per year: 4

INR Option (BDH):

• Number of investigations per year: 4
• Number of control samples per investigation: 1 or 2
• Number of samples per year: 6

D-Dimer Option (BDDI):

• Number of investigations per year: 4
• Number of control samples per investigation: 1 or 2
• Number of samples per year: 6

3 – List of analytes assessed 

Biochemistry / Hematology (BDB) option:

• Creatinine
• CRP*
• Glucose
• HbA1c
• hCG**
• Hematocrit
• Hemoglobin
• Lactates
• Urea

INR Option (BDH):

• INR

D-Dimer Option (BDDI):

• D-Dimer

4 – Description of the control samples

Biochemistry / Hematology (BDB) option:

Liquid human blood (1.2 mL samples, ready to use). Sampling carried out on the day of dispatch, delivered within 24 hours and to be assayed on the day of receipt.

INR Option (BDH):

Liquid human plasma (0.3 mL samples, ready to use)

D-Dimer Option (BDDI):

Liquid human plasma (0.5 mL samples, ready to use)

INR Option (BDH): The samples are compatible with iSTAT by ABBOTT, Xprecia Stride by SIEMENS and CoaguCheck by ROCHE. If you are using other analyzers: contact us.